Milan, Italy and Houston, TX, September 23, 2015 - Sorin S.p.A. (MTA; Reuters Code: SORN.MI) ('Sorin'), a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. (NASDAQ: CYBX, 'Cyberonics'), a medical device company with core expertise in neuromodulation, announced today that the High Court of England and Wales has issued an order approving completion of the cross-border merger (the 'Sorin Merger') of Sorin with and into LivaNova PLC ('LivaNova') following the adoption of the transaction agreement (the 'Transaction Agreement') providing for the business combination between Sorin and Cyberonics by Cyberonics stockholders on September 22, 2015.

click here to view the release

distributed by